Ichor Life Sciences Expands Ophthalmology Capabilities with Christopher Schillo’s Appointment as Vivarium Director
July 6, 2022
LaFayette, N.Y. – Ichor Life Sciences, a premium pre-clinical contract research organization offering services in discovery through pharmacology, announces the hiring of Christopher Schillo as its new vivarium director to expand the company’s ophthalmology capabilities and capacity.
Schillo is responsible for overseeing all operations within the vivarium, which includes managing staff, animal husbandry, and research operations as well as acting as Ichor’s Institutional Animal Care and Use Committee (IACUC) Chair, a requirement for all vivarium’s that house USDA species.
Prior to joining Ichor, Schillo served as the Director of Preclinical Operations for Ora, Inc., a leading provider of eye research for pharmaceutical companies, where he oversaw pre-clinical operations and provided expertise in ocular drug development. At Ichor, Schillo will augment Ichor’s current offerings, including ophthalmology, oncology, geriatrics and more.
“During his time at Ora, Chris proved his expertise in ophthalmology and ability to manage a world-class vivarium,” says Dr. Kelsey Moody, PhD, MBA, and chief executive officer of Ichor Life Sciences. “His appointment expands Ichor’s capability to innovate ophthalmology research practices, in addition to our other therapeutic offerings.”
“It’s exciting to see the level of innovation in life sciences that Ichor has brought to my home region of Central New York,” says Schillo. “I look forward to helping the company expand and grow its capabilities in not just ophthalmology, but a wider scope of offerings as well.”